Home Applications 213973 Application 213973
Type NDA
Sponsor DECIPHERA PHARMACEUTICALS LLC Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 QINLOCK RIPRETINIB TABLET;ORAL 150MG Yes No
Source provenance: Browse the complete Orange Book source catalog · source snapshot 43 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N213973-001 QINLOCK RIPRETINIB 50MG TABLET / ORAL RLD, RS 2020-05-15
Orange Book patents# Current patent rows page 1 of 1 · 42 matching rows.
Orange Book exclusivity# Current exclusivity rows page 1 of 1 · 1 matching rows.
Application-product, Exclusivity code, Expiration table Application-product Exclusivity code Expiration N213973-001 ODE-298 2027-05-15
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-09-14 22:38:34 2026-08 N213973-001 QINLOCK 50MG TABLET / ORAL RLD, RS 2020-05-15 84e616aacf4f…2026-08-18 06:07:40 2026-07 N213973-001 QINLOCK 50MG TABLET / ORAL RLD, RS 2020-05-15 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N213973-001 QINLOCK 50MG TABLET / ORAL RLD, RS 2020-05-15 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N213973-001 QINLOCK 50MG TABLET / ORAL RLD, RS 2020-05-15 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N213973-001 QINLOCK 50MG TABLET / ORAL RLD, RS 2020-05-15 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N213973-001 QINLOCK 50MG TABLET / ORAL RLD, RS 2020-05-15 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N213973-001 QINLOCK 50MG TABLET / ORAL RLD, RS 2020-05-15 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N213973-001 QINLOCK 50MG TABLET / ORAL RLD, RS 2020-05-15 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N213973-001 QINLOCK 50MG TABLET / ORAL RLD, RS 2020-05-15 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N213973-001 QINLOCK 50MG TABLET / ORAL RLD, RS 2020-05-15 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N213973-001 QINLOCK 50MG TABLET / ORAL RLD, RS 2020-05-15 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N213973-001 QINLOCK 50MG TABLET / ORAL RLD, RS 2020-05-15 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N213973-001 QINLOCK 50MG TABLET / ORAL RLD, RS 2020-05-15 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N213973-001 QINLOCK 50MG TABLET / ORAL RLD, RS 2020-05-15 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N213973-001 QINLOCK 50MG TABLET / ORAL RLD, RS 2020-05-15 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N213973-001 QINLOCK 50MG TABLET / ORAL RLD, RS 2020-05-15 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N213973-001 QINLOCK 50MG TABLET / ORAL RLD, RS 2020-05-15 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 N213973-001 QINLOCK 50MG TABLET / ORAL RLD, RS 2020-05-15 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 N213973-001 QINLOCK 50MG TABLET / ORAL RLD, RS 2020-05-15 4b0b4de00fa7…2022-03-09 01:35 UTC 2022-03 N213973-001 QINLOCK 50MG TABLET / ORAL RLD, RS 2020-05-15 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 N213973-001 QINLOCK 50MG TABLET / ORAL RLD, RS 2020-05-15 782e0a99824c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 N213973-001 QINLOCK 50MG TABLET / ORAL RLD, RS 2020-05-15 87673890dc5c…2021-03-12 10:30 UTC 2021-03 N213973-001 QINLOCK 50MG TABLET / ORAL RLD, RS 2020-05-15 5aa47cf7b7d7…2020-12-22 03:56 UTC 2020-12 N213973-001 QINLOCK 50MG TABLET / ORAL RLD, RS 2020-05-15 8869cabd3fbd…2020-11-12 02:37 UTC 2020-11 N213973-001 QINLOCK 50MG TABLET / ORAL RLD, RS 2020-05-15 c0c555d07b60…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 N213973-001 QINLOCK 50MG TABLET / ORAL RLD, RS 2020-05-15 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 N213973-001 QINLOCK 50MG TABLET / ORAL RLD, RS 2020-05-15 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 N213973-001 QINLOCK 50MG TABLET / ORAL RLD, RS 2020-05-15 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 N213973-001 QINLOCK 50MG TABLET / ORAL RLD, RS 2020-05-15 a72a2bbeb626…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 N213973-001 QINLOCK 50MG TABLET / ORAL RLD, RS 2020-05-15 9b2671bbb829…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 N213973-001 QINLOCK 50MG TABLET / ORAL RLD, RS 2020-05-15 a67488948f0b…2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 N213973-001 QINLOCK 50MG TABLET / ORAL RLD, RS 2020-05-15 3f0d92c62455…2023-05-13 08:27 UTC 2023-05 N213973-001 QINLOCK 50MG TABLET / ORAL RLD, RS 2020-05-15 053a50430f4f…2023-01-26 05:58 UTC 2023-01 N213973-001 QINLOCK 50MG TABLET / ORAL RLD, RS 2020-05-15 3bdfa0b2c4d7…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 N213973-001 QINLOCK 50MG TABLET / ORAL RLD, RS 2020-05-15 3a93d1ddd44b…2022-10-28 04:53 UTC 2022-10 N213973-001 QINLOCK 50MG TABLET / ORAL RLD, RS 2020-05-15 f41ea6bd6efb…2022-09-29 23:25 UTC 2022-09 N213973-001 QINLOCK 50MG TABLET / ORAL RLD, RS 2020-05-15 e64feba35796…2022-07-09 03:26 UTC · 3 captures of this ZIP 2022-07 N213973-001 QINLOCK 50MG TABLET / ORAL RLD, RS 2020-05-15 cb3db0bc1861…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N213973-001 QINLOCK 50MG TABLET / ORAL RLD, RS 2020-05-15 a50c72e98297…
Observed Orange Book patent history# Patent history page 22 of 22 · 842 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N213973-001 11969414 2041-02-08 U-3897 2024-05-08 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N213973-001 11779572 2042-10-06 U-3714 2023-11-02 a50c72e98297…
Observed Orange Book exclusivity history# Exclusivity history page 1 of 2 · 74 observed states.
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application# NDC listings for this application page 1 of 1 · 5 matching rows.
NDC, Name, Nonproprietary name table NDC Name Nonproprietary name Labeler Marketing category Status 73207-101 QINLOCK Ripretinib Deciphera Pharmaceuticals, LLC NDA Current 73207-101 QINLOCK Ripretinib Deciphera Pharmaceuticals, LLC NDA Current 73207-101 QINLOCK Ripretinib Deciphera Pharmaceuticals, LLC NDA Current 73207-101 QINLOCK Ripretinib Decipera Pharmaceuticals, LLC NDA Current 73207-101 QINLOCK Ripretinib Deciphera Pharmaceuticals, LLC NDA Current
Documents# Document, Submission type, Date table Document Submission type Date 82166 SUPPL 2025-05-08 82209 SUPPL 2025-05-06 75978 SUPPL 2023-10-27 75963 SUPPL 2023-10-27 73076 SUPPL 2023-01-04 73067 SUPPL 2023-01-03 72109 SUPPL 2022-09-19 72092 SUPPL 2022-09-16 67864 SUPPL 2021-06-22 67853 SUPPL 2021-06-22 63589 ORIG 2020-06-17 63093 ORIG 2020-05-19 63053 ORIG 2020-05-15